Retigraph 20% Injection

Overview Retigraph 20% Injection

Prior to ophthalmic examinations, Retigraph 20% Injection is administered to highlight ocular tissue. Its staining action selectively targets compromised cells within the eye, facilitating the identification of corneal irregularities and aiding in the diagnosis of various eye conditions. Administration of Retigraph 20% Injection must be performed by a qualified medical professional within a hospital or clinic; self-injection is strictly prohibited. This injection typically presents a favorable safety profile with minimal adverse reactions. Nevertheless, any suspected injection-related symptoms should be promptly reported to your physician. Following injection, if visual acuity or responsiveness is impaired, refrain from driving until fully recovered.

Primary Ingredients of Retigraph 20% Injection

No text provided to rephrase.

Uses of Retigraph 20% Injection

Ophthalmologic assessment

Major Benefits of Retigraph 20% Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Retigraph 20% Injection:

• No common side effects seen

How to use Retigraph 20% Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Retigraph 20% Injection works:

OcuBright 20% Injection, an amber-hued dye, temporarily stains compromised ocular cells, enabling ophthalmologists to pinpoint corneal irregularities and diagnose specific eye conditions.

What if you forget to take Retigraph 20% Injection :

Omitting a scheduled dose of Retigraph 20% Injection warrants immediate physician consultation.